Clinical trial
Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety…
NCT00389064 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00389064 |
|---|---|
| Title | Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder |
| Official title | A Multi-Centre, Double-Blind, Randomised, Parallel-Group, Placebo-Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR) in the Treatment of Elderly Patients With Generalised Anxiety Disorder |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anxiety Disorders |
| Intervention type | Drug |
| Interventions | Quetiapine XR, Placebo |
| Enrollment | 450 |
| Start date | Sep 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Oct 18, 2006 |
| Last update posted | Apr 4, 2012 |
| Countries | Estonia, Poland, Russia, Ukraine, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: